UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

Gut, 2000-10, Vol.47 (4), p.487-496

2000

Volltextzugriff (PDF)

Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism

Alimentary pharmacology & therapeutics, 2012-09, Vol.36 (5), p.449-458

2012

Volltextzugriff (PDF)

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density

Gut, 2004-08, Vol.53 (8), p.1129-1136

2004

Volltextzugriff (PDF)

High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis

Gut, 2001-11, Vol.49 (5), p.671-677

2001

Volltextzugriff (PDF)

Antibodies to CBir1 Flagellin Define a Unique Response That Is Associated Independently With Complicated Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2005-06, Vol.128 (7), p.2020-2028

2005

Volltextzugriff (PDF)

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease

Gastroenterology (New York, N.Y. 1943), 1999-12, Vol.117 (6), p.1278-1287

1999

Volltextzugriff (PDF)

Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU)

Endoscopy, 2008-01, Vol.40 (1), p.30-35

2008

Volltextzugriff (PDF)

Long‐term outcomes of thalidomide in refractory Crohn's disease

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (5), p.429-437

2015

Volltextzugriff (PDF)

Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors’ reply

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (8), p.786-786

2015

Volltextzugriff (PDF)

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

Gastroenterology (New York, N.Y. 1943), 1999-10, Vol.117 (4), p.761-769

1999

Volltextzugriff (PDF)

Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease

Gastroenterology (New York, N.Y. 1943), 2004-02, Vol.126 (2), p.414-424

2004

Volltextzugriff (PDF)

Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report

Gastroenterology (New York, N.Y. 1943), 2001-03, Vol.120 (4), p.995-999

2001

Volltextzugriff (PDF)

Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression

The American journal of gastroenterology, 2006-02, Vol.101 (2), p.360-367

2006

Volltextzugriff (PDF)

Infliximab in the treatment of medically refractory indeterminate colitis

Alimentary pharmacology & therapeutics, 2003-10, Vol.18 (7), p.741-747

2003

Volltextzugriff (PDF)

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

Gastroenterology (New York, N.Y. 1943), 1996-06, Vol.110 (6), p.1810-1819

1996

Volltextzugriff (PDF)

Linkage of Crohn’s disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-κB activation

Gut, 2009-01, Vol.58 (1), p.60-67

2009

Volltextzugriff (PDF)

Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis

The American journal of gastroenterology, 2000-08, Vol.95 (8), p.2000-2008

2000

Volltextzugriff (PDF)

An open‐label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6‐mercaptopurine therapy

Inflammatory bowel diseases, 2001-08, Vol.7 (3), p.181-189

2001

Volltextzugriff (PDF)

A pilot study of adalimumab in infliximab‐allergic patients

Inflammatory bowel diseases, 2004-07, Vol.10 (4), p.333-338

2004

Volltextzugriff (PDF)

The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase‐2 inhibitors in patients with inflammatory bowel disease

Inflammatory bowel diseases, 2004-07, Vol.10 (4), p.352-356

2004

Volltextzugriff (PDF)

Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children

Clinical gastroenterology and hepatology, 2008-10, Vol.6 (10), p.1105-1111

2008

Volltextzugriff (PDF)

Immortal Beloved

Cambridge quarterly, 2013-03, Vol.42 (1), p.79-87

Vasiliauskas, Emily

2013

Volltextzugriff (PDF)

Crohn’s ileitis after liver transplantation from a living related donor with Crohn’s disease

Gut, 2004-09, Vol.53 (9), p.1389-1390

2004

Volltextzugriff (PDF)

Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications

Diseases of the colon & rectum, 1999-05, Vol.42 (5), p.601-606

1999

Volltextzugriff (PDF)

New Clinical Method for Distinguishing D-IBS from Other Gastrointestinal Conditions Causing Diarrhea: The LA/IBS Diagnostic Strategy

Digestive diseases and sciences, 2010-01, Vol.55 (1), p.145-149

2010

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(97)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(61)
Humans
(53)
Gastroenterology & Hepatology
(43)
Female
(40)
Male
(40)
Adult
(34)
Biological And Medical Sciences
(28)
Medical Sciences
(26)
Middle Aged
(25)
Adolescent
(17)
Aged
(16)
Gastroenterology. Liver. Pancreas. Abdomen
(15)
Other Diseases. Semiology
(13)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(13)
Treatment Outcome
(12)
Child
(11)
Crohn Disease - Immunology
(11)
Inflammatory Bowel Disease
(11)
Crohn Disease - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density

High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis

Antibodies to CBir1 Flagellin Define a Unique Response That Is Associated Independently With Complicated Crohn’s Disease

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease

Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU)

Long‐term outcomes of thalidomide in refractory Crohn's disease

Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors’ reply

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease

Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report

Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression

Infliximab in the treatment of medically refractory indeterminate colitis

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

Linkage of Crohn’s disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-κB activation

Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis

An open‐label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6‐mercaptopurine therapy

A pilot study of adalimumab in infliximab‐allergic patients

The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase‐2 inhibitors in patients with inflammatory bowel disease

Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children

Immortal Beloved

Crohn’s ileitis after liver transplantation from a living related donor with Crohn’s disease

Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications

New Clinical Method for Distinguishing D-IBS from Other Gastrointestinal Conditions Causing Diarrhea: The LA/IBS Diagnostic Strategy

Suchergebnisse filtern